US 9687532
Sialylated glycoprotein compositons and uses thereof
granted A61KA61K38/47A61K45/06
Quick answer
US patent 9687532 (Sialylated glycoprotein compositons and uses thereof) held by Ultragenyx Pharmaceutical Inc. expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ultragenyx Pharmaceutical Inc.
- Grant date
- Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/47, A61K45/06, A61K9/0019, A61P